UBS Group
DVAX

UBS Group’s Dynavax Technologies DVAX Stock Holding History

UBS Group’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-260,511
Closed -$4.01M – 10646
2025
Q4 		$4.01M Sell
260,511
-196,621
-43% -$2.17M ﹤0.01% 4249
2025
Q3 		$4.54M Buy
457,132
+51,264
+13% +$534K ﹤0.01% 4140
2025
Q2 		$4.03M Sell
405,868
-136,230
-25% -$1.44M ﹤0.01% 4092
2025
Q1 		$7.03M Buy
542,098
+291,239
+116% +$3.85M ﹤0.01% 3432
2024
Q4 		$3.2M Buy
250,859
+7,486
+3% +$90.5K ﹤0.01% 4262
2024
Q3 		$2.71M Buy
243,373
+48,104
+25% +$530K ﹤0.01% 3694
2024
Q2 		$2.19M Sell
195,269
-247,557
-56% -$2.88M ﹤0.01% 3686
2024
Q1 		$5.5M Sell
442,826
-205,085
-32% -$2.68M ﹤0.01% 2873
2023
Q4 		$9.06M Buy
647,911
+525,012
+427% +$7.29M ﹤0.01% 2183
2023
Q3 		$1.82M Sell
122,899
-181,862
-60% -$2.56M ﹤0.01% 3532
2023
Q2 		$3.94M Buy
304,761
+81,445
+36% +$928K ﹤0.01% 2816
2023
Q1 		$2.19M Sell
223,316
-207,009
-48% -$2.21M ﹤0.01% 3322
2022
Q4 		$4.58M Buy
430,325
+311,084
+261% +$3.61M ﹤0.01% 2587
2022
Q3 		$1.25M Buy
119,241
+12,092
+11% +$158K ﹤0.01% 3562
2022
Q2 		$1.35M Sell
107,149
-185,866
-63% -$1.97M ﹤0.01% 3469
2022
Q1 		$3.18M Buy
293,015
+262,650
+865% +$3.19M ﹤0.01% 3006
2021
Q4 		$427K Buy
30,365
+5,312
+21% +$87.4K ﹤0.01% 5105
2021
Q3 		$481K Sell
25,053
-23,742
-49% -$315K ﹤0.01% 4762
2021
Q2 		$481K Sell
48,795
-140,223
-74% -$1.27M ﹤0.01% 4763
2021
Q1 		$1.86M Buy
189,018
+167,361
+773% +$1.38M ﹤0.01% 3635
2020
Q4 		$96K Sell
21,657
-2,554
-11% -$11.6K ﹤0.01% 5707
2020
Q3 		$105K Buy
24,211
+14,627
+153% +$104K ﹤0.01% 5149
2020
Q2 		$85K Sell
9,584
-31,168
-76% -$158K ﹤0.01% 5425
2020
Q1 		$144K Sell
40,752
-38,611
-49% -$179K ﹤0.01% 4975
2019
Q4 		$454K Buy
79,363
+10,735
+16% +$57.4K ﹤0.01% 4923
2019
Q3 		$245K Buy
68,628
+48,250
+237% +$187K ﹤0.01% 5086
2019
Q2 		$82K Sell
20,378
-26,208
-56% -$152K ﹤0.01% 5522
2019
Q1 		$341K Sell
46,586
-38,181
-45% -$373K ﹤0.01% 4300
2018
Q4 		$776K Buy
84,767
+24,427
+40% +$270K ﹤0.01% 3904
2018
Q3 		$748K Buy
60,340
+47,833
+382% +$647K ﹤0.01% 4102
2018
Q2 		$191K Sell
12,507
-242,180
-95% -$4.19M ﹤0.01% 4976
2018
Q1 		$5.06M Buy
254,687
+162,360
+176% +$2.8M ﹤0.01% 2296
2017
Q4 		$1.73M Sell
92,327
-18,082
-16% -$363K ﹤0.01% 3321
2017
Q3 		$2.37M Buy
110,409
+73,029
+195% +$1.16M ﹤0.01% 2971
2017
Q2 		$361K Buy
37,380
+34,088
+1,035% +$221K ﹤0.01% 4354
2017
Q1 		$20K Sell
3,292
-5,740
-64% -$27.6K ﹤0.01% 6134
2016
Q4 		$36K Sell
9,032
-143,499
-94% -$1.05M ﹤0.01% 6080
2016
Q3 		$1.6M Buy
152,531
+111,686
+273% +$1.61M ﹤0.01% 3043
2016
Q2 		$595K Buy
40,845
+38,553
+1,682% +$659K ﹤0.01% 3766
2016
Q1 		$44K Sell
2,292
-12,048
-84% -$243K ﹤0.01% 5596
2015
Q4 		$347K Buy
14,340
+10,854
+311% +$272K ﹤0.01% 4232
2015
Q3 		$86K Buy
3,486
+1,820
+109% +$51.5K ﹤0.01% 5358
2015
Q2 		$39K Buy
1,666
+24
+1% +$523 ﹤0.01% 6219
2015
Q1 		$37K Buy
1,642
+642
+64% +$12.3K ﹤0.01% 6321
2014
Q4 		$17K Buy
+1,000
New +$15.2K ﹤0.01% 7868

Other funds holding DVAX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

UBS Group's DVAX Position: Q1 2026 in Review

UBS Group sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 260,511 shares — an estimated $4.01M sold.

UBS Group first reported a position in DVAX in Q4 2014 and held it in 45 quarters. The position peaked at $9.06M in Q4 2023. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • UBS Group reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • UBS Group sold 260,511 Dynavax Technologies shares in Q1 2026, an estimated $4.01M.
  • UBS Group first reported a position in Dynavax Technologies in Q4 2014 and held it in 45 quarters.
  • UBS Group's Dynavax Technologies position peaked at $9.06M in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.